Literature DB >> 26156235

Genetic variants influencing response to methotrexate in juvenile idiopathic arthritis and rheumatoid arthritis.

Prabha Ranganathan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26156235     DOI: 10.1007/s00296-015-3318-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  4 in total

Review 1.  Development of biomarkers to optimize pediatric patient management: what makes children different?

Authors:  Jennifer Goldman; Mara L Becker; Bridgette Jones; Mark Clements; J Steven Leeder
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

2.  Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

Authors:  Prabha Ranganathan; Robert Culverhouse; Sharon Marsh; Ami Mody; Tiffany J Scott-Horton; Richard Brasington; Amy Joseph; Virginia Reddy; Seth Eisen; Howard L McLeod
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

Review 3.  Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.

Authors:  Fardina Malik; Prabha Ranganathan
Journal:  Pharmacogenomics       Date:  2013-02       Impact factor: 2.533

4.  5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis.

Authors:  Serena Pastore; Gabriele Stocco; Valentina Moressa; Luigi Zandonà; Diego Favretto; Noelia Malusà; Giuliana Decorti; Loredana Lepore; Alessandro Ventura
Journal:  Rheumatol Int       Date:  2014-09-21       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.